CORT
Closed
Corcept Therapeutics Incorporated
69.31
-4.09 (-5.57%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 73.4
Day's Range: 69.28 - 73.8
Send
sign up or login to leave a comment!
When Written:
21.66
Corcept Therapeutics Incorporated is a pharmaceutical company that specializes in the development and commercialization of drugs for the treatment of severe metabolic and psychiatric disorders. The company was founded in 1998 and is headquartered in Menlo Park, California.
Corcept's primary drug is Korlym, which is used for the treatment of Cushing's syndrome, a rare disorder caused by excess cortisol production. The company is also developing other drugs for the treatment of metabolic and psychiatric disorders, including Cushing's syndrome, bipolar disorder, and major depressive disorder.
Corcept is a publicly traded company and is listed on the NASDAQ stock exchange under the ticker symbol CORT. As of 2021, the company has a market capitalization of over $2 billion.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Corcept's primary drug is Korlym, which is used for the treatment of Cushing's syndrome, a rare disorder caused by excess cortisol production. The company is also developing other drugs for the treatment of metabolic and psychiatric disorders, including Cushing's syndrome, bipolar disorder, and major depressive disorder.
Corcept is a publicly traded company and is listed on the NASDAQ stock exchange under the ticker symbol CORT. As of 2021, the company has a market capitalization of over $2 billion.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!